coteauBeta Get App

XBI

State Street SPDR S&P Biotech ETF
$152.78
-0.30% Oct 21 close
Sector n/a CompareTechnicals
1M3M6M1Y2Y
-5%+10%+25%+40%+55%Oct 2025Oct 2026Apr 2026
XBISPY
1W
+4.1%
1M
-3.4%
3M
+0.4%
6M
+11.4%
YTD
+25.4%
1Y
+40.0%

Live chart

Loading live chart…

What they do

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

For information only · Important disclosures

Grades vs sector

No sector grades for XBI yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Our models

Not held by any of our 5 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 Coteau Long Book
Not in the current book

News

More news
Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy?
Nasdaq · 5h ago

Key stats

52-week range$106.30 – $169.89
Dividend yield0.35%
Valuation and fundamentals

Valuation & fundamentals

No SEC filings found for this ticker (foreign filer, ETF or fund).

Earnings

Next report: –
No EPS history available.

Stats refreshed 2026-10-21 18:15:02 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Free. Not investment advice. Unsubscribe anytime.

coteau

Independent research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksTermsPrivacyData statusSend feedback
Beta 0.9 · Oct 21, 2026